Aspirin May Act as a Catalyst in the Treatment of Schizophrenia
Published By : 22 Oct 2014 | Published By : QYRESEARCH
According to latest research studies, anti inflammatory drugs like estrogen and aspirin, and antioxidant Fluimicil can improve and enhance the effectiveness of schizophrenia treatments.
Hitherto, it has been stated that strengthening the immune system can aid in treating schizophrenia, however, there has been no concrete evidence supporting this.
But, as per research conducted at several universities all across the globe has proved via meta-analysis that not all, but there are some anti-inflammatory drugs that can improve the condition of patients suffering from schizophrenia.
According to analyses, Fluimicil, estrogen, and aspirin exhibit hopeful results as against other types of anti-inflammatories like fatty acids, celecoxib, davunetide, and minocycline. As a matter of fact, these have no significant effect.
There is a certain connection between psychiatric anomalies like bipolar disorder and schizophrenia, and the immune system. Schizophrenia has a linkage with the HLA gene system. This gene system is present on chromosome 6 in human beings and has control over several features of the immune system.
The treatment for schizophrenia has not changed much over the last five decades, even though this disorder affects almost 24 million people all over the world. In fact, the treatment for schizophrenia primarily depends on controlling the dopamine levels in the brain. Controlling dopamine in the brain helps in tackling delusions, and hallucinations; but it has no significant impact on treating problems like poor concentration, low energy levels, and absence of motivation.
Researchers at the Utrecht University’s medical unit have stated that about 30% of the patients show zero response to antipsychotic treatment, but their response to treatment improves when it is coupled with anti-inflammatories. This study as a result, lays emphasis on choosing the most suitable anti-inflammatory.